Russian Research Center of Molecular Diagnostics and Therapy

The Research Center of Molecular Diagnostics and Therapy (RCMDT) is a Russian biotechnology company specializing in the development of immunomodulatory and antiviral peptide-based drugs. Founded in 1991 and headquartered in Moscow, the center focuses on addressing chronic viral infections and secondary immunodeficiencies through innovative molecular research. Its flagship products include Gepon, a synthetic peptide used for treating hepatitis and mucosal infections, and Allokin-alpha, an antiviral agent targeting human papillomavirus and herpes. RCMDT manages the full lifecycle of its products, from molecular discovery and clinical development to manufacturing and commercialization within Russia and the CIS region. The company's research emphasizes the induction of endogenous interferons and the activation of natural killer cells to enhance the host immune response.